Vertex Pharmaceuticals Incorporated (ETR:VX1)

Vertex Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 25, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	111,501	100,171	94,857	69,361	49,095	50,241
Market Cap Growth	5.60%	5.60%	36.76%	41.28%	-2.28%	0.14%
Enterprise Value	103,157	91,039	83,201	60,990	43,745	45,660
Last Close Price	432.15	387.65	371.20	270.10	197.14	191.32
PE Ratio	-	-	28.97	22.31	23.84	22.66
PS Ratio	10.48	9.41	10.62	8.30	7.37	9.90
PB Ratio	7.03	6.32	5.96	5.33	5.53	7.08
P/TBV Ratio	7.96	7.15	6.70	6.07	6.42	8.44
P/FCF Ratio	-	-	31.42	18.89	23.18	20.53
P/OCF Ratio	-	-	29.64	17.95	21.12	18.89
EV/Sales Ratio	10.63	8.55	9.32	7.30	6.57	9.00
EV/EBITDA Ratio	23.80	19.74	20.54	14.40	12.38	17.66
EV/EBIT Ratio	25.50	20.52	21.35	14.89	12.78	18.29
EV/FCF Ratio	-135.14	-	27.56	16.61	20.66	18.66
Debt / Equity Ratio	0.11	0.11	0.05	0.07	0.10	0.11
Debt / EBITDA Ratio	0.36	0.36	0.18	0.20	0.24	0.30
Debt / FCF Ratio	-	-	0.24	0.23	0.40	0.32
Asset Turnover	0.49	0.49	0.48	0.57	0.60	0.62
Inventory Turnover	5.14	5.14	7.38	8.87	8.97	10.62
Quick Ratio	2.17	2.17	3.60	4.46	4.04	4.02
Current Ratio	2.69	2.69	3.99	4.83	4.46	4.33
Return on Equity (ROE)	-3.15%	-3.15%	22.99%	27.67%	24.93%	36.71%
Return on Assets (ROA)	12.68%	12.68%	13.17%	17.33%	19.32%	19.02%
Return on Capital (ROIC)	15.71%	15.71%	16.22%	21.15%	23.51%	23.29%
Return on Capital Employed (ROCE)	24.20%	24.20%	22.50%	28.40%	34.50%	30.90%
Earnings Yield	-0.46%	-0.52%	3.45%	4.48%	4.20%	4.41%
FCF Yield	-0.68%	-0.76%	3.18%	5.29%	4.31%	4.87%
Buyback Yield / Dilution	1.00%	1.00%	-0.54%	0.31%	1.33%	-1.04%

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.